229 related articles for article (PubMed ID: 25705153)
21. Molecular Targets of Nimbolide for Anti-Cancer Therapy: An Updated Review.
Elumalai P; Ezhilarasan D; Raghunandhakumar S
J Environ Pathol Toxicol Oncol; 2022; 41(2):69-88. PubMed ID: 35695653
[TBL] [Abstract][Full Text] [Related]
22. Disruption of Epigenetic Silencing in Human Colon Cancer Cells Lines Utilizing a Novel Supercritical CO
Qiu Z; Andrijauskaite K; Morris J; Wargovich MJ
Anticancer Res; 2019 Oct; 39(10):5473-5481. PubMed ID: 31570441
[TBL] [Abstract][Full Text] [Related]
23. Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways.
Singh PR; Priya ES; Balakrishnan S; Arunkumar R; Sharmila G; Rajalakshmi M; Arunakaran J
Biomed Pharmacother; 2016 Dec; 84():1623-1634. PubMed ID: 27889231
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of colon cancer (HT-29) cell proliferation by a triterpenoid isolated from Azadirachta indica is accompanied by cell cycle arrest and up-regulation of p21.
Roy MK; Kobori M; Takenaka M; Nakahara K; Shinmoto H; Tsushida T
Planta Med; 2006 Aug; 72(10):917-23. PubMed ID: 16858664
[TBL] [Abstract][Full Text] [Related]
25. Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.
Elumalai P; Brindha Mercy A; Arunkamar R; Sharmila G; Bhat FA; Balakrishnan S; Raja Singh P; Arunakaran J
Cell Prolif; 2014 Dec; 47(6):540-52. PubMed ID: 25377085
[TBL] [Abstract][Full Text] [Related]
26. Quinone reductase inducers in Azadirachta indica A. Juss flowers, and their mechanisms of action.
Sritanaudomchai H; Kusamran T; Kuakulkiat W; Bunyapraphatsara N; Hiransalee A; Tepsuwan A; Kusamran WR
Asian Pac J Cancer Prev; 2005; 6(3):263-9. PubMed ID: 16235984
[TBL] [Abstract][Full Text] [Related]
27. Nimbolide induced apoptosis by activating ERK-mediated inhibition of c-IAP1 expression in human hepatocellular carcinoma cells.
Hsueh KC; Lin CL; Tung JN; Yang SF; Hsieh YH
Environ Toxicol; 2018 Sep; 33(9):913-922. PubMed ID: 29962003
[TBL] [Abstract][Full Text] [Related]
28. Nimbolide retards T cell lymphoma progression by altering apoptosis, glucose metabolism, pH regulation, and ROS homeostasis.
Jaiswara PK; Kumar A
Environ Toxicol; 2022 Jun; 37(6):1445-1457. PubMed ID: 35199915
[TBL] [Abstract][Full Text] [Related]
29. First report on the pharmacokinetic profile of nimbolide, a novel anticancer agent in oral and intravenous administrated rats by LC/MS method.
Baira SM; Khurana A; Somagoni J; Srinivas R; Godugu C; Talluri MVNK
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():191-198. PubMed ID: 29908468
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of amide derivatives of nimbolide.
Sastry BS; Suresh Babu K; Hari Babu T; Chandrasekhar S; Srinivas PV; Saxena AK; Madhusudana Rao J
Bioorg Med Chem Lett; 2006 Aug; 16(16):4391-4. PubMed ID: 16793266
[TBL] [Abstract][Full Text] [Related]
31. Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide.
Arumugam A; Subramani R; Lakshmanaswamy R
Mol Ther Oncolytics; 2021 Mar; 20():596-606. PubMed ID: 33768141
[TBL] [Abstract][Full Text] [Related]
32. Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways.
Rahmani AH; Al Zohairy MA; Aly SM; Khan MA
Biomed Res Int; 2014; 2014():761608. PubMed ID: 25295272
[TBL] [Abstract][Full Text] [Related]
33. Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling.
Lin H; Qiu S; Xie L; Liu C; Sun S
Biomed Pharmacother; 2017 Aug; 92():340-346. PubMed ID: 28554129
[TBL] [Abstract][Full Text] [Related]
34. An Overview on the Anticancer Activity of
Moga MA; Bălan A; Anastasiu CV; Dimienescu OG; Neculoiu CD; Gavriș C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563141
[TBL] [Abstract][Full Text] [Related]
35. Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases.
Patel SM; Nagulapalli Venkata KC; Bhattacharyya P; Sethi G; Bishayee A
Semin Cancer Biol; 2016 Oct; 40-41():100-115. PubMed ID: 27019417
[TBL] [Abstract][Full Text] [Related]
36. Molecular Docking of Nimbolide Extracted from Leaves of
Navinraj S; Boopathi NM; Balasubramani V; Nakkeeran S; Raghu R; Gnanam R; Saranya N; Santhanakrishnan VP
Indian J Microbiol; 2023 Dec; 63(4):494-512. PubMed ID: 38031617
[TBL] [Abstract][Full Text] [Related]
37. Combination of Nimbolide and TNF-α-Increases Human Colon Adenocarcinoma Cell Death through JNK-mediated DR5 Up- regulation.
Chantana C; Yenjai C; Reubroycharoen P; Waiwut P
Asian Pac J Cancer Prev; 2016; 17(5):2637-41. PubMed ID: 27268643
[TBL] [Abstract][Full Text] [Related]
38. Intracellular, biofilm-inhibitory and membrane-damaging activities of nimbolide isolated from Azadirachta indica A. Juss (Meliaceae) against meticillin-resistant Staphylococcus aureus.
Sarkar P; Acharyya S; Banerjee A; Patra A; Thankamani K; Koley H; Bag PK
J Med Microbiol; 2016 Oct; 65(10):1205-1214. PubMed ID: 27553840
[TBL] [Abstract][Full Text] [Related]
39. The Highly Pure Neem Leaf Extract, SCNE, Inhibits Tumorigenesis in Oral Squamous Cell Carcinoma via Disruption of Pro-tumor Inflammatory Cytokines and Cell Signaling.
Morris J; Gonzales CB; De La Chapa JJ; Cabang AB; Fountzilas C; Patel M; Orozco S; Wargovich MJ
Front Oncol; 2019; 9():890. PubMed ID: 31572681
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the chemopreventive potential of neem leaf subfractions in the hamster buccal pouch model and phytochemical characterization.
Manikandan P; Ramalingam SM; Vinothini G; Ramamurthi VP; Singh IP; Anandan R; Gopalakrishnan M; Nagini S
Eur J Med Chem; 2012 Oct; 56():271-81. PubMed ID: 22939101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
